Dr Lal PathLabs acquires 70% stake in SN Genelab for ₹168 cr

Dr Lal PathLabs approved acquisition of a 70% stake in SN Genelab Private Ltd, a Gujarat-based genomics diagnostics firm, for up to ₹168 crore cash plus a ₹31.5 crore performance-linked earn-out. The deal aims to strengthen genomics expertise. SN Gene posted ₹57.96 crore turnover in FY26. The transaction is expected to close by November 30, 2026.